120 related articles for article (PubMed ID: 32620958)
1. Novel mobile application for direct communication between pharmacists and patients treated with oral antineoplastic agents.
Collado-Borrell R; Escudero-Vilaplana V; Ribed A; Jiménez RR; Peinado II; Herranz-Alonso A; Sanjurjo-Sáez M
Am J Health Syst Pharm; 2020 Aug; 77(17):1393-1402. PubMed ID: 32620958
[TBL] [Abstract][Full Text] [Related]
2. Design of the functional requirements of a smartphone app for patients receiving oral antineoplastic agents: The e-OncoSalud® app.
Collado-Borrell R; Escudero-Vilaplana V; Ribed A; Anglada-Martínez H; Martín-Conde M; Herranz-Alonso A; Codina-Jané C; Sanjurjo-Sáez M
J Oncol Pharm Pract; 2020 Jan; 26(1):105-115. PubMed ID: 30955468
[TBL] [Abstract][Full Text] [Related]
3. Effect of a Mobile App for the Pharmacotherapeutic Follow-Up of Patients With Cancer on Their Health Outcomes: Quasi-Experimental Study.
Collado-Borrell R; Escudero-Vilaplana V; Ribed A; Gonzalez-Anleo C; Martin-Conde M; Romero-Jimenez R; Iglesias-Peinado I; Herranz-Alonso A; Sanjurjo-Saez M
JMIR Mhealth Uhealth; 2020 Oct; 8(10):e20480. PubMed ID: 33064100
[TBL] [Abstract][Full Text] [Related]
4. A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital.
Villanueva-Bueno C; Collado-Borrell R; Escudero-Vilaplana V; Revuelta-Herrero JL; Marzal-Alfaro MB; González-Haba E; Arranz-Arija JÁ; Osorio S; Herranz-Alonso A; Sanjurjo-Saez M
Front Public Health; 2022; 10():978783. PubMed ID: 36407983
[TBL] [Abstract][Full Text] [Related]
5. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction.
Ribed A; Romero-Jiménez RM; Escudero-Vilaplana V; Iglesias-Peinado I; Herranz-Alonso A; Codina C; Sanjurjo-Sáez M
Int J Clin Pharm; 2016 Apr; 38(2):280-8. PubMed ID: 26715547
[TBL] [Abstract][Full Text] [Related]
7. Survey of oral chemotherapy safety and adherence practices of hospitals in Spain.
Conde-Estévez D; Salas E; Albanell J
Int J Clin Pharm; 2013 Dec; 35(6):1236-44. PubMed ID: 24129581
[TBL] [Abstract][Full Text] [Related]
8. Design Considerations in the Development of App-Based Oral Anticancer Medication Management Systems: a Qualitative Evaluation of Pharmacists' and Patients' Perspectives.
Ali EE; Chan SSL; Poh HY; Susanto YA; Suganya T; Leow JL; Pang CK; Chew L; Yap KY
J Med Syst; 2019 Feb; 43(3):63. PubMed ID: 30726518
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy follow-up of key points in the safety of oral antineoplastic agents.
Escudero-Vilaplana V; Ribed A; Romero-Jimenez RM; Herranz-Alonso A; Sanjurjo-Saez M
Eur J Cancer Care (Engl); 2017 May; 26(3):. PubMed ID: 26872286
[TBL] [Abstract][Full Text] [Related]
10. Impact of oncology pharmacist-managed oral anticancer therapy in patients with chronic myelogenous leukemia.
Lam MS; Cheung N
J Oncol Pharm Pract; 2016 Dec; 22(6):741-748. PubMed ID: 26419691
[TBL] [Abstract][Full Text] [Related]
11. Hospital pharmacists' and patients' views about what constitutes effective communication between pharmacists and patients.
Chevalier BAM; Watson BM; Barras MA; Cottrell WN
Int J Pharm Pract; 2018 Oct; 26(5):450-457. PubMed ID: 29210472
[TBL] [Abstract][Full Text] [Related]
12. Oral antineoplastic agents: assessment of safety and dose adjustments in clinical practice.
Escudero-Vilaplana V; Revuelta-Herrero JL; Collado-Borrell R; Marzal-Alfaro B; Gimenez-Manzorro A; Herranz-Alonso A; Sanjurjo-Saez M
Expert Opin Drug Saf; 2019 Sep; 18(9):861-868. PubMed ID: 31282227
[No Abstract] [Full Text] [Related]
13. Development and implementation of an interdisciplinary oncology program in a community hospital.
Chung C; Collins A; Cui N
Am J Health Syst Pharm; 2011 Sep; 68(18):1740-7. PubMed ID: 21880891
[TBL] [Abstract][Full Text] [Related]
14. Pharmacists' roles in oncology pharmacy services: Results of a global survey.
Holle LM; Harris CS; Chan A; Fahrenbruch RJ; Labdi BA; Mohs JE; Norris LB; Perkins J; Vela CM
J Oncol Pharm Pract; 2017 Apr; 23(3):185-194. PubMed ID: 26854267
[TBL] [Abstract][Full Text] [Related]
15. Impact of pharmacist consultation at clinical trial inclusion: an effective way to reduce drug-drug interactions with oral targeted therapy.
Leenhardt F; Alexandre M; Guiu S; Pouderoux S; Beaujouin M; Lossaint G; Philibert L; Evrard A; Jacot W
Cancer Chemother Pharmacol; 2021 Oct; 88(4):723-729. PubMed ID: 34286354
[TBL] [Abstract][Full Text] [Related]
16. Guiding pharmacist clinical interviews: a safety tool to support the education of patients treated with oral antineoplastic agents.
Ribed A; Escudero-Vilaplana V; Romero-Jimenez RM; Iglesias-Peinado I; Herranz-Alonso A; Sanjurjo-Saez M
Expert Opin Drug Saf; 2016; 15(4):427-35. PubMed ID: 26854363
[TBL] [Abstract][Full Text] [Related]
17. Oncology Patient Interest in the Use of New Technologies to Manage Their Disease: Cross-Sectional Survey.
Collado-Borrell R; Escudero-Vilaplana V; Calles A; Garcia-Martin E; Marzal-Alfaro B; Gonzalez-Haba E; Herranz-Alonso A; Sanjurjo-Saez M
J Med Internet Res; 2018 Oct; 20(10):e11006. PubMed ID: 30355554
[TBL] [Abstract][Full Text] [Related]
18. Investigating strategies used by hospital pharmacists to effectively communicate with patients during medication counselling.
Chevalier BAM; Watson BM; Barras MA; Cottrell WN
Health Expect; 2017 Oct; 20(5):1121-1132. PubMed ID: 28370932
[TBL] [Abstract][Full Text] [Related]
19. Hospital pharmacists' perceptions of medication counseling: A focus group study.
Chevalier BA; Watson BM; Barras MA; Cottrell WN
Res Social Adm Pharm; 2016; 12(5):756-71. PubMed ID: 26626591
[TBL] [Abstract][Full Text] [Related]
20. 2018 Hematology/Oncology Pharmacist Association Best Practices for the Management of Oral Oncolytic Therapy: Pharmacy Practice Standard.
Mackler E; Segal EM; Muluneh B; Jeffers K; Carmichael J
J Oncol Pract; 2019 Apr; 15(4):e346-e355. PubMed ID: 30860937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
